<DOC>
	<DOCNO>NCT01579409</DOCNO>
	<brief_summary>In France , primary cardiovascular metabolic prevention support French National Program Nutrition Health ( PNNS : Programme National Nutrition Santé ) . The investigator make hypothesis , independently diseases , non adherence PNNS guideline would lead arterial stiffness , endothelial dysfunction , change microcirculation cardiac autonomic system . These change may exist fast also reinforce standardise breakfast . The investigator aim evaluate arterial stiffness , endothelial function , microcirculation cardiac autonomic system accord PNNS status case control study .</brief_summary>
	<brief_title>The Impact French PNNS Guidelines Vascular Function Following Standardised Breakfast .</brief_title>
	<detailed_description>This case / control pilot nest SU.VI.MAX 2 ( SUpplémentation en VItamines et Minéraux Anti-oXydants ) study . The randomized longitudinal placebo control SU.VI.MAX study test preventive effect vitamin antioxidant mineral supplementation incidence mortality cardiovascular pathology cancer . SU.VI.MAX 2 extension previous study include 7200 subject food habit know characterized accord PNNS guideline ( PNNS score ) . The subject pre-selected original cohort SU.VI.MAX2 PNNS score 2007 1-40th 60-100th percentile distribution . If accept participate , new PNNS score calculate 2012-2013 subject 1-25th 75-100th percentile include explored one day participation . Our aim evaluate arterial stiffness , endothelial function , microcirculation cardiac autonomic system accord PNNS status case control study . Our secondary objective evaluate parameter subject breakfast contain 75 g glucose .</detailed_description>
	<criteria>Social Security affiliation . Participation SU.VI.MAX 2 . Subjects without legal guardian freely agree participate study . PNNS score 2012 low ( case ) upper ( control ) quartile . Known diabetes prediabetes inclusion . History cardiovascular disease . Treatment hypertension . Treatment dyslipidemia . Known Cancer Smoking patient stop smoke less 3 year Cardiac pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Nutrition</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Microcirculation</keyword>
	<keyword>Cardiac autonomic system .</keyword>
</DOC>